62009TO0275_EN
Subject of the case
Operative part
Subject of the case
Re:
ACTION for annulment of the decision in the letter of the Commission addressed to the applicant on 6 May 2009 in the context of the procedure for authorising the placing on the market of Lunivia, inasmuch as it concerns classification of the active substance eszopiclone.
Operative part
Operative part
1. The action is dismissed as inadmissible.
2. Sepracor Pharmaceuticals (Ireland) Ltd is ordered to pay the costs.